Comparison of muscle relaxants in clinical use.
A prospective clinical comparison of d-tubocurarine, alcuronium, gallamine and pancuronium was performed in 400 surgical patients. Various parameters usually followed during clinical anaesthesia were recorded from the beginning of, to the recovery from anaesthesia. Endotracheal intubation was performed with or without suxamethonium. Intubation was always possible in 1-3 min when  different muscle relaxants were used in the following initial doses: d-tubocurarine 0.4 mg/kg, alcuronium 0.3 mg/kg, gallamine 1.8 mg/kg, and suxamethonium 0.8 mg/kg. However, there was a statistically significant inferiority of the d-tubocurarine and gallamine groups. The use of suxamethonium seemed to shorten the duration of the initial dose of the nondepolarising agents and also to increase especially the dose of gallamine when calculated as mg/kg/h. It should be mentioned that the non-depolarising agents were given soon after suxamethonium without waiting for the return of spontaneous respiration. Pancuronium and alcuronium caused least changes in the cardiovascular parameters. Erythematous skin reactions were seen mostly after the use of d-tubocurarine and suxamethonium. This could depend on histamine liberating potency of these muscle relaxants.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects; D000443:Alcuronium / Q000008:administration & dosage / Q000009:adverse effects; D000768:Anesthesia, General; D001794:Blood Pressure / Q000187:drug effects; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D005703:Gallamine Triethiodide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects; D010197:Pancuronium / Q000008:administration & dosage / Q000009:adverse effects; D011446:Prospective Studies; D011674:Pulse; D013390:Succinylcholine / Q000008:administration & dosage / Q000009:adverse effects; D014403:Tubocurarine / Q000008:administration & dosage / Q000009:adverse effects
D000759:Adjuvants, Anesthesia; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D000443:Alcuronium; D014403:Tubocurarine